v3.26.1
STOCK OPTIONS AND WARRANTS
6 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
STOCK OPTIONS AND WARRANTS

NOTE 14 - STOCK OPTIONS AND WARRANTS

 

Stock Option

 

On April 5, 2021, the Company entered into a Consulting Agreement with a third-party consultant for her marketing and promoting services provided to xSigma Corporation. Pursuant to the Consulting Agreement, the Company issued 35,714 stock options (250,000 stock options prior to split), of which 7,143 options (50,000 options prior to split) are exercisable upon execution of the Consulting Agreement and the 28,571 stock options (200,000 stock options prior to split) shall vest in four equal instalments on a quarterly basis (7,143 shares every three months). The Company estimates the fair value of the share-based option awards on the date of grant using the Black-Scholes option-pricing model (the “Black-Scholes model”). Using the Black-Scholes model, the value of the award that is ultimately expected to vest is recognized over the requisite service period in the statement of operations. The Company attributes compensation to expense using the straight-line single option method for the options granted.

 

A summary of stock option activity for the six months ended March 31, 2026, is presented below:

 

   Shares   Weighted
Average
   Remaining
Contractual
   Grant-
Date
 
   underlying
Options
   Exercise
Price
   Term
(Years)
   Fair
Value
 
       $         
Outstanding at October 1, 2025   35,714    70    
        -
    1,085,386 
Granted   -    -    -    - 
Exercised   -    -    -    - 
Forfeited   -    -    -    - 
Outstanding at March 31, 2026   35,714    70    -    1,085,386 
Exercisable at March 31, 2026   35,714    70    
-
    1,085,386 

Stock Warrants

 

As of March 31, 2026, the Company had outstanding 14,102 warrants (98,716 stock warrants prior to split) issued in connection with the consulting arrangement and stock offering. The following is a summary of the change in outstanding warrants during the six months ended March 31, 2026:

 

   Shares
Underlying
Options/
   Weighted
Average
Exercise
   Weighted
Average
Remaining
Contractual
Term
 
   Warrants   Price   (Years) 
       $     
Outstanding at October 1, 2025   14,102    1.38    0.42 
Granted   -    -    - 
Exercised   -    -    - 
Forfeited   -    -    - 
Outstanding at March 31, 2026   14,102    1.38    
-
 
Exercisable at March 31, 2026   14,102    1.38    
-